Science Explorer Back to mapMap
Discussion
Researcher · Saitama Medical University · Japan

Hiroshi Kagamu

Hiroshi Kagamu publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0003-4523-8517 OpenAlex
World rank
#2,236,552
of 7,710,434 ranked researchers
Rank in Japan
#42,881
of 383,136
Works
358
Citations
4.2k
Citations per work
11.9
h-index
33
i10-index 99Top 9.4% in Oncology
Hiroshi Kagamu

What does Hiroshi Kagamu research?

Hiroshi Kagamu's work is mostly in Medicine (62%), Immunology and Microbiology (11%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 220 works · 61.5% of their workMedicine: 220 works · 61.5% of their workOncology: 115 works · 32.1% of their workPulmonary and Respiratory Medicine: 84 works · 23.4% of their workNeurology: 11 works · 3.1% of their workEpidemiology: 10 works · 2.9% of their workEverything else: 84 works · 23.5% of their workLife Sciences: 54 works · 15.0% of their workImmunology and Microbiology: 41 works · 11.4% of their workImmunology: 41 works · 11.4% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 3.6% of their workMolecular Biology: 13 works · 3.6% of their workTHEIR WORKHiroshi Kagamu358works
Life Sciences15%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine22061.5%
  2. Everything else8423.5%
    1. Immunology and Microbiology4111.4%
    2. Biochemistry, Genetics and Molecular Biology133.6%
  1. 1Oncology32% of their works
  2. 2Pulmonary and Respiratory Medicine23% of their works
  3. 3Immunology11% of their works
  4. 4Molecular Biology4% of their works
  5. 5Neurology3% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Hiroshi Kagamu's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Chemotherapy, ALK Inhibitors, EGFR Mutations and Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Clinical Trials1352 topics
  2. Targeted Therapy1352 topics
  3. Immune Checkpoint Blockade1181 topic
  4. PD-1 and PD-L11181 topic
  5. Chemotherapy1062 topics
  6. ALK Inhibitors851 topic
  7. EGFR Mutations851 topic
  8. Immunotherapy792 topics
  9. Cancer Immunotherapy762 topics
  10. CT Screening561 topic
  11. Lung Cancer561 topic
  12. Genomic Profiles501 topic
  13. Small-Cell Lung Cancer501 topic
  14. Dendritic Cells471 topic
  15. Immunity471 topic
  16. CAR T Cells291 topic
  17. Chimeric Antigen Receptor291 topic
  18. NK Cell Recognition241 topic
  19. Natural Killer Cells241 topic
  20. Allergic Diseases181 topic
  21. Asthma181 topic

Where does Hiroshi Kagamu work?

Hiroshi Kagamu's main affiliation in the publication record is Saitama Medical University, Japan.

How many publications and citations does Hiroshi Kagamu have?

OpenAlex counts 358 works and 4,248 citations for Hiroshi Kagamu, an h-index of 33, ranking #2,236,552 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hiroshi Kagamu. Posts are plain text and can be reported.